HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sami Aboumatar Selected Research

Cenobamate

6/2022Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures.
1/2022Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
12/2021Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
12/2021Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
1/2020Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sami Aboumatar Research Topics

Disease

5Seizures (Absence Seizure)
06/2022 - 01/2020
3Epilepsy (Aura)
01/2022 - 01/2021
1Drug Hypersensitivity Syndrome
01/2020

Drug/Important Bio-Agent (IBA)

5CenobamateIBA
06/2022 - 01/2020
2perampanelIBA
01/2022 - 01/2021
1Pharmaceutical PreparationsIBA
12/2021